VALN

Companies
NASDAQ
Valneva SE
Health Care
Price Chart
Overview

About VALN

Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden and Vienna, Austria, with other offices in France, Canada and the United States.

Market Cap
$583.3M
Volume
54.0K
Avg. Volume
528.7K
P/E Ratio
-11.446428
Dividend Yield
0.00%
Employees
688.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.59
Low Correlation
Volatility
High (0.72)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for VALN.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, VALN shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$583.3M
Volume54.0K
P/E Ratio-11.45
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how VALN fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025